• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bruker Announces Acquisition of Magnettech’s EPR Business

Share:

October 15, 2019

Bruker (Nasdaq: BRKR) today announced the acquisition of the Magnettech EPR business from Freiberg Instruments GmbH, and the establishment of a related, long-term EPR supply partnership with Freiberg Instruments. Financial details of the transaction were not disclosed.

Magnettech’s benchtop electron paramagnetic resonance (EPR) system, the MiniScope MS 5000, and a broad range of Magnettech EPR accessories, expand Bruker’s existing EPR portfolio. With this addition, Bruker’s EPR product line now includes compact micro-EPR systems, dedicated or research-grade benchtop EPR systems, as well as a range of floor-standing research EPR systems for many different EPR molecular and materials research applications, and dedicated polymer and beverage analysis solutions.

Freiberg Instruments, which has developed and is manufacturing the MiniScope MS 5000 EPR products, and Bruker have also agreed to a long-term EPR supply partnership, and Bruker intends to continue to work with some of Magnettech’s key channel partners, in particular Aerial for the important market of radiation processing and dosimetry. Bruker is welcoming all Magnettech EPR customers with a strong commitment to global service, applications and software support, and to ongoing further EPR developments.

Dr. Falko Busse, Group President of Bruker BioSpin, stated: “We are excited by the opportunities of the Magnettech EPR business in new market segments. This acquisition complements our EPR offerings, so that we can now address most EPR customers’ requirements in molecular research and in chemical and applied markets quality control and process analysis. The long-term supply and innovation partnership with Freiberg Instruments establishes an agile EPR ecosystem that combines the strengths of both companies.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Dr. Kay Dornich, Managing Director of Freiberg Instruments GmbH, commented: “I am delighted that Bruker has acquired our EPR business to provide the MS 5000 benchtop system and related dedicated EPR analysis solutions, as well as global service and support. Freiberg is pleased to continue an EPR supply partnership with Bruker.”

EPR spectroscopy, also known as Electron Spin Resonance (ESR), is the molecular method of choice to detect, quantify and characterize paramagnetic species, unpaired electrons, free radicals, reactive oxygen species and transition metal complexes. This makes EPR uniquely suitable for selected scientific research applications and certain chemistry QC and food analysis solutions.

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Apple Pulls 181 Vaping-related Apps from Store Worldwide, Cites Health IssuesApple Pulls 181 Vaping-related Apps from Store Worldwide, Cites Health Issues
  • Impact of Covid-19 on Pharma Regulatory Management Systems MarketImpact of Covid-19 on Pharma Regulatory Management Systems Market
  • Novo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore BiotechNovo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore Biotech
  • Pharma and Cetirizine OTC Market 2020 |Global Industry Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2026Pharma and Cetirizine OTC Market 2020 |Global Industry Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2026
  • Cellarity Takes in $123 Million to Drive Cell-Centric Drug Discovery Toward ClinicCellarity Takes in $123 Million to Drive Cell-Centric Drug Discovery Toward Clinic
  • DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology DatabasesDeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases
  • QXMédical Licenses Bioresorbable Embolic Technology from U of MNQXMédical Licenses Bioresorbable Embolic Technology from U of MN
  • Non-Invasive, Precision-Based Approaches for Diagnosis and Treatment of Inflammatory Skin ConditionsNon-Invasive, Precision-Based Approaches for Diagnosis and Treatment of Inflammatory Skin Conditions

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications